Clinical Trials Browser

Ashwagandha × Clear all

NCT04092647 2023-06-15

Ashwagandha for Cognitive Dysfunction

Phase 2 Unknown

Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction

NCT00689195 2011-06-23

OSCAT

Phase 1/2 Unknown

Osteosarcoma

NCT00817752 2010-03-18

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

Phase 1 Completed

Autoimmune Diseases, Inflammation, Neoplasms